A Review of Acute Myocardial Injury in Coronavirus Disease 2019
- PMID: 32642342
- PMCID: PMC7336683
- DOI: 10.7759/cureus.8426
A Review of Acute Myocardial Injury in Coronavirus Disease 2019
Abstract
In December 2019, an outbreak of pneumonia caused by a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), occurred in Wuhan, Hubei province, China, and it has spread rapidly across the world, causing the coronavirus disease 2019 (COVID-19) pandemic. Although SARS-CoV-2 infection predominantly results in pulmonary issues, accumulating evidence suggests the increased frequency of a variety of cardiovascular complications in patients with COVID-19. Acute cardiac injury, defined as elevated cardiac troponin levels, is the most reported cardiac abnormality in COVID-19 and strongly associated with mortality. In this article, we summarize the currently available data on the association of SARS-CoV-2 and COVID-19 with acute myocardial injury.
Keywords: acute myocardial injury; cardiac troponin; covid-19; myocarditis; sars-cov-2.
Copyright © 2020, B K et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
References
-
- WHO: novel coronavirus (COVID-19) situation reports. [May;2020 ];5] S. I. N. http://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation... vol. 2019, no. April. 2020
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous